Aydincan Akdur, Turkey
Posterior reversible encephalopathy syndrome in transplant patients: diagnosis and management

Miss Yao Deng, People's Republic of China
4-Octyl itaconate inhibits T cells’ proliferation and aerobic glycolysis to prevent immune over activation

Shaifali Sandal, Canada
Granulocyte colony-stimulating factor with or without immunosuppression reduction in neutropenic kidney transplant recipients

Prof. Puxun Tian, People's Republic of China
Human Primary Renal Tubuloids as Tools for Calcineurin inhibitor Nephrotoxicity Assessment

Dr. Alessandro Mattina, Italy
Safety of once-weekly dulaglutide on post-transplant diabetes mellitus: a preliminary single-centre experience

Dr. Mario Abbud-Filho Sr., Brazil
Distinct FOXP3 gene expression in the peripheral blood and inside renal allografts is associated with use of mTOR inhibitors and extended criteria kidney donor

Miss Lei Dong, People's Republic of China
Risk prediction model for immunosuppressive medication nonadherence in kidney transplantation recipients

Mr. Rens Kraaijeveld, Netherlands
Effects of bcl-6 inhibition on the humoral alloresponse

Dr. Sangkyun Mok, Korea
Determination of tacrolimus dosage using machine learning in kidney transplantation

Dr. Matej Vnučák, Slovakia (Slovak Republic)
The impact of different induction immunosuppression protocol on patient survival, graft survival and acute graft rejection after kidney transplantation – multicenter study